AP/Miami Herald examines potential use of H1N1 vaccine A strain-specific vaccine for the H1N1 flu virus, known as the swine flu also, that potentially could possibly be developed by researchers may not be as beneficial as some might hope because uninsured U silagra .S. Citizens are unlikely to get the vaccine, the AP/Miami Herald reports. Based on the AP/Herald, uninsured U.S. Residents likely will be forced to select between going to the emergency section, potentially ‘flooding’ EDs, or self-medicating. Many uninsured U.S. Citizens are unaware that many community health centers and doctors’ offices offer no-price or reduced cost services for low-income individuals, the AP/Herald reports. Based on the AP/Herald, untreated uninsured U.S.
Food and Medication Administration to advertise Aztreonam for Injection, USP in two dosage strengths. APP’s Aztreonam is normally AP-rated, latex-free and bar-coded. Relating to IMS data, 2009 sales of the branded product in the United States were approximately $86 million. The approval of Aztreonam further expands APP’s leading anti-infective products. ‘The approval of APP’s Aztreonam marks the first generic entrant in to the market and provides clinicians with an alternative to the branded medication,’ stated John Ducker, president and chief executive officer of APP Pharmaceuticals. ‘APP’s entry into the market also provides hospitals with yet another source of supply because of this anti-infective medicine, which continues to be shown on the FDA and the American Culture of Health-System Pharmacists medication shortage lists since the summer of 2009.’..